We have just published our new consolidated screening standards for the NHS Cervical Screening Programme.
National Cervical Screening Programme Manager
Ruth was appointed as Programme Manager for the Cervical Screening programme in October 2015. The Programme Manager leads on the operational management of the cervical screening programme.
Ruth has a wealth of experience and knowledge in the Cervical Screening Programme. For the previous 12 years Ruth worked in the Screening Quality Assurance Service for the Cervical Screening programme undertaking a variety of roles most recently as a Senior QA Advisor. She has a background in Primary Care and Practice Nursing. In her previous roles she has been employed as a Marie Curie Training Facilitator for Cervical Screening, a PCT Primary Care Cancer lead and as a Clinical Manager in Contraceptive Services.
Ruth enjoys spending time with her family and cats, watching Mad Men (the box series) attempting yoga, and swimming.
PHE is responsible for setting policy and guidance for the NHS Cervical Screening Programme. To make sure we have clinical expertise to support and advise the programme we have clinical professional groups for laboratories, colposcopy, education and training.
Ruth Stubbs, PHE's Cervical Screening Programme Manager, shares how the plans for introducing HPV primary screening are coming along.
Cervical cancer is preventable and the impact of a diagnosis is far reaching both emotionally and physically. Screening is a choice that is available to all women, and by raising awareness we are ensuring women receive the information to help them make an informed choice.
NHS England has published a statement regarding commissioning decisions for HPV primary screening in the cervical screening programme.
Every time we work on an e-learning project we try to think about who works in screening and what they need to help provide safe and efficient services. Last week, the NHS Cervical Screening Programme (CSP) launched a new e-learning …
Evidence shows that human papillomavirus (HPV) testing is a better way of identifying women at risk of cervical cancer than the cytology (smear) test that examines cells under a microscope.
Cervical screening prevents cancer by detecting abnormalities of the cervix and referring women for potential treatment.
We are pleased to publish the sample taker training guidance for the NHS Cervical Screening Programme, replacing the previous publication ‘A Resource Pack for Trainers’ (April 2006).
PHE screening team members and clinicians attended the 40th European Congress of Cytology in Liverpool.